跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 60 条关于
“CDKN1A”
全部
60
临床试验
31
药物
22
机构
0
资讯
7
上个月
Ractigen Therapeutics Secures U.S. FDA IND Clearance for First-in-Class saRNA Therapy RAG-1C Targeting Proliferative Vitreoretinopathy
5个月前
Signadori Bio Appoints Dr. Selwyn Ho as CEO to Advance Novel Monocyte Immunotherapy Platform
去年
Cyclacel Completes Enrollment in Fadraciclib Trial for Tumors with CDKN2A/B Abnormalities
去年
Insilico Medicine Develops Novel AI-Designed CDK12/13 Inhibitors for Treatment-Resistant Cancers
5年前
FDA Lifts Partial Clinical Hold on RVU120 Trial in AML and MDS
去年
CDK1 and TDP1 Inhibition Synergistically Overcomes Cancer Drug Resistance
去年
Carrick Therapeutics Initiates Phase 1 Trial of Novel CDK12/13 Inhibitor CT7439 in Advanced Solid Tumors